Meet the people who want peptides to be made in America

A group of venture capitalists hosted an event on a historic ship to advocate for domestic manufacturing of peptides in the United States. The event highlights the tension between the growing demand for experimental peptides and the FDA's concerns over safety and clinical trial standards.
Why it matters
The debate over peptide sourcing reflects broader concerns about the regulation of the booming wellness and pharmaceutical supply chain.
This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they’re going to change your life. We’ll be taking a break next week and will be back on November 25th. Opt in for Optimizer here.
The SS Jeremiah O’Brien is a World War II Liberty ship. The hulking vessel was built in 56 days. It made 11 trips to Normandy, France, to supply the Allied powers in the fight against German U-boats. Last week, it was the site of a black-tie peptide party thrown by a trio of Gen Z venture capitalists.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in